Formation of Health Professionals Through in Situ Simulation to Improve Performances During the Initial Step of Thrombectomy for Ischemic Strokes

Time Clinical Trial

— OPTISS  

Official title:

Optimization of Performances During Thrombectomy Through In Situ Simulation

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03738371
• Other study ID #: OPTISS
• Status: Recruiting
• Start date: October 1, 2018
• Est. completion date: December 1, 2019

Study information

• Verified date: November 2018
• Source: Hospices Civils de Lyon
• Contact: Lionel BAPTESTE, MD
• Phone: 0472357944
• Email: lionel.bapteste[@]chu-lyon.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The thrombectomy is an emergency care provided as soon as possible to selected patients suffering from ischemic strokes. Many steps are necessary to prepare this specialized procedure of interventional neuroradiology, including installation and preparation of the patient for this act. This first and essential time required the intervention of many health professionals.

The approach consists of a series of formation through in situ simulations for these health professionals, in order to improve and optimize this first step of the procedure (from the installation of the patient to the percutaneous punch by the neuroradiologist).

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 50
• Est. completion date: December 1, 2019
• Est. primary completion date: October 1, 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• voluntary professionals

Related Conditions & MeSH terms

• Benefit of in Situ Simulation for This Kind of Training
• Installation of the Patient Until the Percutaneous
• Time

Intervention

Other:
• In situ simulation
Team involved in thrombectomy procedures will be trained by in situ simulation. Simulation will reproduce the initial step of a thrombectomy procedure, i.e from from the installation of the patient to the percutaneous punch by the neuroradiologist. Simulation will be followed by a debriefing focused on the team performance. Three in situ simulation sessions will be realized by each team.

Locations

Country	Name	City	State
France	Hôpital neurologique, Centre Hospitalier Universitaire	Lyon

Sponsors (1)

Lead Sponsor	Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Performance of the team	Performance of the team will be scored using a technical and non-technical skill.	12 months